Depression
Commentary
Chatbots can improve mental health in vulnerable populations
Taking greater advantage of these automated agents could save $11 billion across business sectors by 2023, said Sammi Wong and Dr. Krysti Lan Chi...
Conference Coverage
Cannabis use: Messages remain mixed across diagnoses
Medscape Live and this news organization are owned by the same parent company. Dr. Martinez and Dr. Sarris reported no financial conflicts of...
News
Pandemic drives uptick in need for mental health services
Women were more likely than men to have received any mental health treatment (25.6% vs 14.6%), according to an analysis of 2020 data.
Commentary
To meme or not to meme: The likability and ‘virability’ of memes
Memes can target emotional pain, neutralize the threat, and turn discomfort into a discourse of playfulness and warmth, said Leanna M.W. Lui.
Commentary
An integrated response to Surfside: Lessons learned
Our hope is that a better understanding of these strategies will help future therapists and responders who respond to crises.
From the Journals
Sleep problems in mental illness highly pervasive
“This suggests there may need to be even more of an emphasis on sleep in these patients than there already is,” said Dr. Michael Wainberg.
Conference Coverage
‘Impressive’ results for novel antidepressant, so why the FDA delay?
Results showed the drug had a clinical response rate of 80% and a remission rate of almost 70%.
Conference Coverage
Lower thyroid hormone levels a red flag for elevated suicide risk?
Patients with suicidal ideation were 54% less likely to have higher TSH levels.
From the Journals
What turns wandering thoughts into something worse?
The more negative someone’s thoughts became, the more likely that their next idea would be related to their previous one, researchers found.
News from the FDA/CDC
Anxiety, depression symptoms rose and fell with new COVID cases
Despite decreasing this spring, symptom frequency remained elevated over estimates from 2019.
Conference Coverage
Steroid a promising short-term treatment option for major depression?
“These data continue to support the development of zuranolone as a potential 14-day short course treatment” for MDD episodes, said Dr. Colville...